
IndraLab
Statements
sparser
"In the context of atherosclerosis, interference with MIF binding to both CXCR2 and CXCR4 by using a MIF blocking antibody interfered with MIF’s pro-atherosclerotic functions (Bernhagen et al., xref ), while it would leave the protective homeostatic functions of the CXCL12-CXCR4 axis preserved (Koenen and Weber, xref )."